AbbVie Inc (ABBV) is trading at $254.49 up 0.04% over the past 24 hours. Its Galaxy Score is 29.3, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 118K engagements and 323 posts with 92% positive social sentiment.
AI summary: AbbVie Inc. is a large-cap immunology-focused pharma stock with momentum from its immunology pipeline, but faces price and policy risk due to drug pricing debates. Immunology momentum is aiding ABBV’s price action, but ongoing pricing policy uncertainty caps upside; the stock is trading with a buoyant but cautious tilt as investors await policy clarity to validate further gains.
AbbVie Inc (ABBV) is tracked on LunarCrush, where you can follow its price alongside live social activity and sentiment across X, Reddit, YouTube and other networks.
AbbVie Inc (ABBV) is trading at $254.49, up 0.04% over the past 24 hours.
$ABBV has a Galaxy Score of 29.3 — LunarCrush's 0–100 measure combining an asset's market and social performance.
Yes. $ABBV social sentiment is 92% positive across social posts over the last 24 hours.
There have been 323 posts about $ABBV over the last 24 hours.
On LunarCrush — follow $ABBV's real-time social sentiment, engagement and market activity across X, Reddit, YouTube, TikTok and news in one place.